Stay updated with breaking news from Beck Bode. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Beck Bode LLC lessened its stake in Pfizer Inc. (NYSE:PFE – Get Rating) by 15.7% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 6,114 shares of the biopharmaceutical company’s stock after selling 1,142 shares during the period. Beck […]
Beck Bode LLC lessened its holdings in Visa Inc. (NYSE:V – Get Rating) by 63.0% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 2,009 shares of the credit-card processor’s stock after selling 3,414 shares during the quarter. Beck Bode LLC’s holdings in Visa were […]
PDD (NASDAQ:PDD – Get Rating) had its target price cut by Citigroup from $115.00 to $100.00 in a research report released on Tuesday morning, The Fly reports. Other equities analysts also recently issued research reports about the company. Morgan Stanley upgraded PDD from an equal weight rating to an overweight rating and upped their target […]
Boston Partners increased its stake in shares of NexTier Oilfield Solutions Inc. (NYSE:NEX – Get Rating) by 27.6% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 4,317,224 shares of the company’s stock after buying an additional 934,921 shares during the quarter. […]
Beck Bode LLC purchased a new stake in shares of Novo Nordisk A/S (NYSE:NVO – Get Rating) in the 4th quarter, Holdings Channel reports. The fund purchased 4,811 shares of the company’s stock, valued at approximately $651,000. Several other hedge funds and other institutional investors have also recently made changes to their positions in NVO. […]